Changes of The Reimbursement Recommendations Focused on Oncology Drugs Before and after The Implementation of The 2013 Benefit Enhancement Policy in Korea
Abstract
Authors
EJ Hwang S Jang S So
EJ Hwang S Jang S So
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now